A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
Clinical trial NCT03816163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03816163
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-15
- Primary completion
- 2026-08-31
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.